Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sex differences in the decline of neutralizing antibodies to SARS-CoV-2

View ORCID ProfileLudivine Grzelak, View ORCID ProfileAurélie Velay, View ORCID ProfileYoann Madec, Floriane Gallais, Isabelle Staropoli, Catherine Schmidt-Mutter, Marie-Josée Wendling, Nicolas Meyer, View ORCID ProfileCyril Planchais, David Rey, View ORCID ProfileHugo Mouquet, Ludovic Glady, Yves Hansmann, Timothée Bruel, Jérome De Sèze, Arnaud Fontanet, View ORCID ProfileMaria Gonzalez, View ORCID ProfileOlivier Schwartz, View ORCID ProfileSamira Fafi-Kremer
doi: https://doi.org/10.1101/2020.11.12.20230466
Ludivine Grzelak
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
2Sorbonne Paris Cité, Université de Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ludivine Grzelak
Aurélie Velay
3CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
4Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aurélie Velay
Yoann Madec
5Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoann Madec
Floriane Gallais
3CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
4Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Staropoli
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Schmidt-Mutter
6Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Josée Wendling
3CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
4Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Meyer
7CHU de Strasbourg, Service de santé Publique, GMRC, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cyril Planchais
8Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cyril Planchais
David Rey
9CHU de Strasbourg, Pôle SMO, le Trait d’Union, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo Mouquet
8Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hugo Mouquet
Ludovic Glady
10CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Hansmann
11CHU de Strasbourg, Service des infectieuses et tropicales, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothée Bruel
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérome De Sèze
6Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
12CHU de Strasbourg, Service de Neurologie, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnaud Fontanet
5Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Gonzalez
13CHU de Strasbourg, Service de Pathologies Professionnelles, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Gonzalez
Olivier Schwartz
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
14Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Schwartz
  • For correspondence: olivier.schwartz@pasteur.fr samira.fafi-kremer@chru-strasbourg.fr
Samira Fafi-Kremer
3CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
4Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samira Fafi-Kremer
  • For correspondence: olivier.schwartz@pasteur.fr samira.fafi-kremer@chru-strasbourg.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The evolution of SARS-CoV-2 humoral response in infected individuals remains poorly characterized. Here, we performed a longitudinal study of sera from 308 RT-qPCR+ individuals with mild disease, collected at two time-points, up to 6 months post-onset of symptoms (POS). We performed two anti-S and one anti-N serology assays and quantified neutralizing antibodies (NAbs). At month 1 (M1), males, individuals > 50 years of age or with a body mass index (BMI) > 25 exhibited higher levels of antibodies. Antibody levels decreased over time. At M3-6, anti-S antibodies persisted in 99% of individuals while anti-N IgG were measurable in only 59% of individuals. The decline in anti-S and NAbs was faster in males than in females, independently of age and BMI. Our results show that some serology tests are less reliable overtime and suggest that the duration of protection after SARS-CoV-2 infection or vaccination will be different in women and men.

Competing Interest Statement

SFK, YM, RG, LT, FA, PS, CSM, NC, AB, AV, NL, MM, NM, DR, BH, JDS and AF have no competing interest to declare. LG, IS, TB, and OS are holder of a provisional patent on the S-Flow assay

Clinical Trial

NCT04441684

Clinical Protocols

https://clinicaltrials.gov/ct2/show/study/NCT04441684

Funding Statement

SFK lab is funded by Strasbourg University Hospitals (SeroCoV-HUS; PRI 7782), the Agence Nationale de la Recherche (ANR-18-CE17-0028), Laboratoire d'Excellence TRANSPLANTEX (ANR-11-LABX-0070_TRANSPLANTEX), and Institut National de la Sante et de la Recherche Medicale (UMR_S 1109). O.S. is funded by Institut Pasteur, Urgence COVID-19 Fundraising Campaign of Institut Pasteur, ANRS, Sidaction, the Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), "TIMTAMDEN" ANR-14-CE14-0029, "CHIKV-Viro-Immuno" ANR-14-CE14-0015-01, and the Gilead HIV cure program. ANR/Fondation Pour la Recherche Medicale Flash COVID. LG is supported by the French Ministry of Higher Education, Research and Innovation. The funders had no role in study design, data collection, interpretation, or the decision to submit the work for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study has been approved by the CPP (comite de protection des personnes) SUD MEDITERRANEE III, Number 2020.04.15 bis_ 20.04.10.66856 and has been registered at ClinicalTrials.gov under the identifier: NCT04441684

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* co-first authors

  • ↵& co-last authors

Data Availability

All data are available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sex differences in the decline of neutralizing antibodies to SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sex differences in the decline of neutralizing antibodies to SARS-CoV-2
Ludivine Grzelak, Aurélie Velay, Yoann Madec, Floriane Gallais, Isabelle Staropoli, Catherine Schmidt-Mutter, Marie-Josée Wendling, Nicolas Meyer, Cyril Planchais, David Rey, Hugo Mouquet, Ludovic Glady, Yves Hansmann, Timothée Bruel, Jérome De Sèze, Arnaud Fontanet, Maria Gonzalez, Olivier Schwartz, Samira Fafi-Kremer
medRxiv 2020.11.12.20230466; doi: https://doi.org/10.1101/2020.11.12.20230466
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Sex differences in the decline of neutralizing antibodies to SARS-CoV-2
Ludivine Grzelak, Aurélie Velay, Yoann Madec, Floriane Gallais, Isabelle Staropoli, Catherine Schmidt-Mutter, Marie-Josée Wendling, Nicolas Meyer, Cyril Planchais, David Rey, Hugo Mouquet, Ludovic Glady, Yves Hansmann, Timothée Bruel, Jérome De Sèze, Arnaud Fontanet, Maria Gonzalez, Olivier Schwartz, Samira Fafi-Kremer
medRxiv 2020.11.12.20230466; doi: https://doi.org/10.1101/2020.11.12.20230466

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9003)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)